Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $13,994 | 307 | 51.2% |
| Consulting Fee | $9,078 | 3 | 33.2% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $1,684 | 2 | 6.2% |
| Travel and Lodging | $1,581 | 4 | 5.8% |
| Education | $690.81 | 11 | 2.5% |
| Honoraria | $300.00 | 1 | 1.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Edwards Lifesciences Corporation | $11,198 | 24 | $0 (2024) |
| Abbott Laboratories | $2,541 | 25 | $0 (2024) |
| BIOTRONIK INC. | $2,431 | 24 | $0 (2024) |
| Amgen Inc. | $2,176 | 40 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $1,150 | 37 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $873.80 | 12 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $862.29 | 38 | $0 (2024) |
| SANOFI-AVENTIS U.S. LLC | $782.60 | 6 | $0 (2019) |
| Medtronic Vascular, Inc. | $600.66 | 3 | $0 (2019) |
| Boston Scientific Corporation | $572.18 | 8 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $13,613 | 60 | Edwards Lifesciences Corporation ($10,862) |
| 2023 | $1,597 | 44 | BIOTRONIK INC. ($271.59) |
| 2022 | $1,752 | 39 | Abbott Laboratories ($618.07) |
| 2021 | $1,540 | 45 | BIOTRONIK INC. ($456.61) |
| 2020 | $1,397 | 33 | Abbott Laboratories ($641.67) |
| 2019 | $2,852 | 36 | SANOFI-AVENTIS U.S. LLC ($646.42) |
| 2018 | $1,769 | 32 | BIOTRONIK INC. ($271.98) |
| 2017 | $2,808 | 39 | Abbott Laboratories ($665.40) |
All Payment Transactions
328 individual payment records from CMS Open Payments — Page 3 of 14
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 03/22/2024 | Merck Sharp & Dohme LLC | VERQUVO (Drug), VERQUVO | Food and Beverage | In-kind items and services | $22.28 | General |
| Category: CARDIOVASCULAR | ||||||
| 03/13/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $21.37 | General |
| Category: Cardiology | ||||||
| 02/15/2024 | BIOTRONIK INC. | BIOMONITOR (Device) | Food and Beverage | In-kind items and services | $179.70 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 02/15/2024 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $17.84 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 02/13/2024 | Boston Scientific Corporation | WATCHMAN FLX (Device) | Food and Beverage | In-kind items and services | $19.50 | General |
| Category: WATCHMAN FLX_IC | ||||||
| 01/31/2024 | PFIZER INC. | ELIQUIS (Drug), PAXLOVID, NURTEC ODT | Food and Beverage | In-kind items and services | $23.43 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 01/25/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug), ENTRESTO | Food and Beverage | In-kind items and services | $21.89 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 01/20/2024 | Novo Nordisk Inc | Ozempic (Drug) | Food and Beverage | In-kind items and services | $23.75 | General |
| Category: Diabetes | ||||||
| 01/18/2024 | Edwards Lifesciences Corporation | SAPIEN 3 Ultra RESILIA (Device) | Food and Beverage | In-kind items and services | $24.65 | General |
| Category: Transcatheter Heart Valves | ||||||
| 01/03/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $14.62 | General |
| Category: Cardiology | ||||||
| 12/22/2023 | iRhythm Technologies, Inc. | ZIO XT Patch (Device) | Food and Beverage | In-kind items and services | $23.54 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 12/20/2023 | Philips North America LLC | (CK4) MCOT (Device) | Food and Beverage | Cash or cash equivalent | $46.41 | General |
| Category: Medical Device | ||||||
| 12/20/2023 | Philips North America LLC | (CK4) MCOT (Device) | Food and Beverage | Cash or cash equivalent | $46.41 | General |
| Category: Medical Device | ||||||
| 12/20/2023 | PFIZER INC. | VYNDAMAX (Drug) | Food and Beverage | In-kind items and services | $30.05 | General |
| Category: CARDIOVASCULAR | ||||||
| 12/02/2023 | Novo Nordisk Inc | Ozempic (Drug) | Food and Beverage | In-kind items and services | $16.66 | General |
| Category: Diabetes | ||||||
| 11/18/2023 | Novo Nordisk Inc | Ozempic (Drug) | Food and Beverage | In-kind items and services | $17.86 | General |
| Category: Diabetes | ||||||
| 11/17/2023 | BIOTRONIK INC. | BIOMONITOR (Device) | Food and Beverage | In-kind items and services | $142.01 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 11/17/2023 | PFIZER INC. | VYNDAMAX (Drug) | Food and Beverage | In-kind items and services | $23.04 | General |
| Category: CARDIOVASCULAR | ||||||
| 11/17/2023 | PFIZER INC. | VYNDAMAX (Drug) | Food and Beverage | In-kind items and services | $17.14 | General |
| Category: CARDIOVASCULAR | ||||||
| 11/10/2023 | Edwards Lifesciences Corporation | SAPIEN 3 Ultra RESILIA (Device) | Food and Beverage | In-kind items and services | $26.96 | General |
| Category: Transcatheter Heart Valves | ||||||
| 11/02/2023 | Alnylam Pharmaceuticals Inc. | AMVUTTRA (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: Genetic Disease | ||||||
| 11/02/2023 | Merck Sharp & Dohme LLC | VERQUVO (Drug), VERQUVO | Food and Beverage | In-kind items and services | $20.66 | General |
| Category: CARDIOVASCULAR | ||||||
| 10/30/2023 | Neurelis, Inc. | VALTOCO (Drug) | Food and Beverage | In-kind items and services | $150.00 | General |
| Category: EPILEPSY | ||||||
| 10/27/2023 | PFIZER INC. | ELIQUIS (Drug), PAXLOVID, NURTEC ODT | Food and Beverage | In-kind items and services | $17.09 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 10/27/2023 | PFIZER INC. | ELIQUIS (Drug), PAXLOVID, NURTEC ODT | Food and Beverage | In-kind items and services | $1.99 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 21 | 1,276 | 2,022 | $301,428 | $90,889 |
| 2022 | 17 | 1,120 | 1,414 | $479,890 | $133,649 |
| 2021 | 11 | 831 | 1,063 | $409,557 | $105,041 |
| 2020 | 18 | 1,294 | 1,862 | $521,644 | $152,673 |
All Medicare Procedures & Services
73 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Office | 2023 | 87 | 89 | $48,813 | $13,625 | 27.9% |
| 78452 | Nuclear medicine studies of heart muscle at rest and with stress and spect | Office | 2023 | 29 | 29 | $39,904 | $11,962 | 30.0% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 71 | 88 | $32,648 | $10,248 | 31.4% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Facility | 2023 | 152 | 173 | $32,739 | $9,211 | 28.1% |
| 93010 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | Facility | 2023 | 563 | 1,137 | $26,172 | $7,817 | 29.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 52 | 73 | $20,236 | $5,467 | 27.0% |
| A9500 | Technetium tc-99m sestamibi, diagnostic, per study dose | Office | 2023 | 29 | 55 | $24,750 | $5,327 | 21.5% |
| 93880 | Ultrasound of both sides of head and neck blood flow | Office | 2023 | 23 | 24 | $10,800 | $3,872 | 35.9% |
| 93925 | Ultrasound of leg arteries or artery grafts | Office | 2023 | 16 | 16 | $6,400 | $3,425 | 53.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 18 | 39 | $4,875 | $3,203 | 65.7% |
| J2785 | Injection, regadenoson, 0.1 mg | Office | 2023 | 19 | 70 | $10,500 | $2,984 | 28.4% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 30 | 42 | $9,450 | $2,961 | 31.3% |
| 93351 | Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report | Office | 2023 | 11 | 11 | $5,500 | $2,402 | 43.7% |
| 93970 | Ultrasound study of arm or leg veins with compression and maneuvers | Office | 2023 | 11 | 11 | $6,050 | $1,871 | 30.9% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Facility | 2023 | 16 | 16 | $6,096 | $1,792 | 29.4% |
| 99284 | Emergency department visit with moderate level of medical decision making | Facility | 2023 | 15 | 15 | $5,190 | $1,626 | 31.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2023 | 11 | 11 | $2,068 | $647.24 | 31.3% |
| 93016 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | Facility | 2023 | 32 | 32 | $1,859 | $580.33 | 31.2% |
| 93320 | Ultrasound of heart blood flow, valves and chambers | Office | 2023 | 11 | 11 | $1,430 | $523.05 | 36.6% |
| 93017 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) | Office | 2023 | 19 | 19 | $2,128 | $497.42 | 23.4% |
| 93018 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | Facility | 2023 | 30 | 30 | $1,170 | $362.70 | 31.0% |
| 93325 | Ultrasound of heart with color-depicted blood flow, rate and valve function | Office | 2023 | 11 | 11 | $1,650 | $244.86 | 14.8% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 20 | 20 | $1,000 | $240.60 | 24.1% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Office | 2022 | 320 | 322 | $305,743 | $58,511 | 19.1% |
| 93229 | Electrocardiogram (ecg) up to 30 days continuous with transmission of patient triggered events with review and report by health care professional | Office | 2022 | 41 | 41 | $47,850 | $33,721 | 70.5% |
About Dr. Savi Mushiyev, MD
Dr. Savi Mushiyev, MD is a Cardiovascular Disease healthcare provider based in Forest Hills, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/01/2008. The National Provider Identifier (NPI) number assigned to this provider is 1013179050.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Savi Mushiyev, MD has received a total of $27,328 in payments from pharmaceutical and medical device companies, with $13,613 received in 2024. These payments were reported across 328 transactions from 33 companies. The most common payment nature is "Food and Beverage" ($13,994).
As a Medicare-enrolled provider, Mushiyev has provided services to 4,521 Medicare beneficiaries, totaling 6,361 services with total Medicare billing of $482,253. Data is available for 4 years (2020–2023), covering 73 distinct procedure/service records.
Practice Information
- Specialty Cardiovascular Disease
- Location Forest Hills, NY
- Active Since 07/01/2008
- Last Updated 12/07/2009
- Taxonomy Code 207RC0000X
- Entity Type Individual
- NPI Number 1013179050
Products in Payments
- EDWARDS SAPIEN 3 TRANSCATHETER HEART VALVE (THV) (Device) $8,745
- Repatha (Biological) $2,066
- XARELTO (Drug) $1,150
- ENTRESTO (Drug) $710.41
- JARDIANCE (Drug) $499.07
- BIOMONITOR (Device) $451.29
- ELIQUIS (Drug) $441.70
- MULTAQ (Drug) $421.78
- VERQUVO (Drug) $416.00
- Edora (Device) $383.98
- PRADAXA (Drug) $374.73
- BioMonitor 2 (Device) $363.38
- FORTIFY ASSURA (Device) $317.48
- Product in Development (Device) $300.00
- VALTOCO (Drug) $300.00
- SAPIEN 3 Ultra RESILIA (Device) $275.74
- Mitra Clip system (Device) $261.46
- PRALUENT (Drug) $238.89
- Fortify Assura, Ellipse ICD (Device) $186.62
- Assurity Pacemaker (Device) $186.51
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Cardiovascular Disease Doctors in Forest Hills
Robert Rahmani, D.o, D.O
Cardiovascular Disease — Payments: $31,456
Dr. Mikhail Kapchits, M.d, M.D
Cardiovascular Disease — Payments: $17,112
Dr. Ronny Cohen
Cardiovascular Disease — Payments: $10,998
Dr. Sepideh Nabatian, Md, MD
Cardiovascular Disease — Payments: $9,213
Dr. Faraidoon Golyan, Do, DO
Cardiovascular Disease — Payments: $7,499
Dr. Sahadeo Ramnauth, Md, MD
Cardiovascular Disease — Payments: $2,588